Thermo Fisher Scientific announced that it is investing US$50 million in its global bioproduction capabilities.
The Bioproduction capabilities will provide additional capacity for manufacturing single-use Bioprocess Container (BPC) systems.
Thermo Fisher's single-use bioprocess container systems are used for sterile liquid-handling applications.
These technologies help to increase productivity and ensure quality in the production of biological drugs.
In the UK, company is supposed to expand assembly capacity and add bioprocess container manufacturing systems. By this expansion, Europe will experience shorten leads time and improved global efficiency.
In the US, Thermo Fisher plans to expand cleanroom space for bioprocess container chambers and related assembly production processes in Logan, Utah, and also, in Millersburg, Pennsylvania.
The expansions are expected to be completed by the end of 2020.
|Thermo Fisher Scientific
|UK and USA
|Scheduled to be operational by 2020